Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
LDLR- |
RCV000238020 | SCV000295788 | likely benign | Hypercholesterolemia, familial, 1 | 2016-03-25 | criteria provided, single submitter | literature only | |
Cardiovascular Research Group, |
RCV000238020 | SCV000322994 | likely benign | Hypercholesterolemia, familial, 1 | 2016-03-01 | criteria provided, single submitter | research | 0/95 non-FH individuals |
Fundacion Hipercolesterolemia Familiar | RCV000238020 | SCV000607660 | likely benign | Hypercholesterolemia, familial, 1 | 2016-03-01 | criteria provided, single submitter | research | |
Gene |
RCV001722277 | SCV000721078 | likely benign | not provided | 2018-07-12 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 26020417, 30333156) |
Labcorp Genetics |
RCV000776112 | SCV000752446 | benign | Familial hypercholesterolemia | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000776112 | SCV000910985 | likely benign | Familial hypercholesterolemia | 2017-06-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002418058 | SCV002719012 | likely benign | Cardiovascular phenotype | 2023-06-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003323476 | SCV004028779 | likely benign | not specified | 2023-07-18 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001722277 | SCV004033642 | likely benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | LDLR: BP4, BP7 |
All of Us Research Program, |
RCV000238020 | SCV004818476 | likely benign | Hypercholesterolemia, familial, 1 | 2024-02-05 | criteria provided, single submitter | clinical testing | |
GENin |
RCV000776112 | SCV005441735 | likely benign | Familial hypercholesterolemia | 2023-02-03 | criteria provided, single submitter | clinical testing | This is a synonymous (silent) variant that is not predicted to impact splicing and occurs at a nucleotide which is not conserved. Therefore this variant has been classified as Likely Benign (BP4, BP7). |
Prevention |
RCV003977703 | SCV004789031 | likely benign | LDLR-related disorder | 2024-02-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |